VV
MDT icon

Verity & Verity’s Medtronic MDT Stock Holding History

Verity & Verity’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.9M Buy
218,510
+15,338
+8% +$1.47M 1.41% 33
2025
Q4 		$19.5M Buy
203,172
+4,598
+2% +$447K 1.52% 26
2025
Q3 		$18.9M Buy
198,574
+4,568
+2% +$420K 1.51% 27
2025
Q2 		$16.9M Sell
194,006
-2,193
-1% -$186K 1.45% 30
2025
Q1 		$17.6M Buy
196,199
+17,418
+10% +$1.56M 1.55% 30
2024
Q4 		$14.3M Buy
178,781
+2,683
+2% +$232K 1.3% 33
2024
Q3 		$15.9M Buy
176,098
+6,316
+4% +$531K 1.55% 27
2024
Q2 		$13.4M Buy
169,782
+4,036
+2% +$331K 1.46% 31
2024
Q1 		$14.4M Sell
165,746
-3,427
-2% -$292K 1.61% 24
2023
Q4 		$13.9M Buy
169,173
+38,091
+29% +$2.9M 1.6% 25
2023
Q3 		$10.3M Buy
131,082
+46,387
+55% +$3.88M 1.29% 35
2023
Q2 		$7.46M Buy
84,695
+11,231
+15% +$967K 0.92% 49
2023
Q1 		$5.92M Buy
73,464
+15,199
+26% +$1.24M 0.76% 54
2022
Q4 		$4.53M Buy
58,265
+4,024
+7% +$326K 0.59% 58
2022
Q3 		$4.38M Buy
54,241
+6,887
+15% +$619K 0.71% 54
2022
Q2 		$4.25M Buy
47,354
+2,857
+6% +$289K 0.65% 60
2022
Q1 		$4.94M Buy
44,497
+4,044
+10% +$427K 0.68% 56
2021
Q4 		$4.18M Buy
40,453
+1,582
+4% +$183K 0.6% 58
2021
Q3 		$4.71M Buy
38,871
+966
+3% +$125K 0.7% 54
2021
Q2 		$4.71M Sell
37,905
-13
-0% -$1.63K 0.74% 54
2021
Q1 		$4.67M Buy
37,918
+3,381
+10% +$396K 0.76% 54
2020
Q4 		$4.09M Buy
34,537
+6,143
+22% +$676K 0.77% 53
2020
Q3 		$2.94M Buy
28,394
+551
+2% +$55.3K 0.65% 58
2020
Q2 		$2.58M Buy
27,843
+2,005
+8% +$192K 0.62% 57
2020
Q1 		$2.33M Sell
25,838
-6,342
-20% -$675K 0.66% 54
2019
Q4 		$3.65M Buy
32,180
+932
+3% +$102K 0.71% 56
2019
Q3 		$3.34M Buy
31,248
+1,524
+5% +$159K 0.71% 55
2019
Q2 		$2.9M Buy
29,724
+12,870
+76% +$1.18M 0.63% 61
2019
Q1 		$1.53M Buy
+16,854
New +$1.51M 0.35% 75

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Verity & Verity's MDT Position: Q1 2026 in Review

Verity & Verity increased its Medtronic (MDT) stake by 7.5% in Q1 2026, buying an estimated $1.47M and bringing the position to 218,510 shares worth $18.9M. The position accounts for 1.41% of the portfolio, ranked #33.

Verity & Verity first reported a position in MDT in Q1 2019 and has held it in 29 quarters since. The position peaked at $19.5M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Verity & Verity held 218,510 shares of Medtronic worth $18.9M as of Q1 2026.
  • Verity & Verity bought 15,338 Medtronic shares in Q1 2026, an estimated $1.47M.
  • Medtronic made up 1.41% of Verity & Verity's portfolio in Q1 2026, its #33 holding.
  • Verity & Verity first reported a position in Medtronic in Q1 2019 and has held it in 29 quarters since.
  • Verity & Verity's Medtronic position peaked at $19.5M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Verity & Verity's 13F filing for Q1 2026, filed 15 Apr 2026.